In my quest to figure out why the stock price is n
Post# of 148190
(Total Views: 495)
Posted On: 11/08/2019 10:11:24 AM
In my quest to figure out why the stock price is not anywhere close to the value of this drug at this point in development, I have a theory. My guess is that the more Gilead (and other BP) shows they are on a different path, developing their own technologies, the biotech market assumes any other drug should not be take seriously.
If I was an analyst in biotech investing, I would look at the likelihood of a partnership/buyout of any drug as a reason to jump in. If BP shows no signs of interest, the drug will need to prove itself with smaller deals. If there was no PR's from Gilead or some other HIV market BP relating to them developing other drugs or some info leak that a partnership was in the works with Leronlimab, I think this is not on the radar at all as a stock investment. As much as we blame the OTC, there are stocks on he OTC that see explosive jumps on good news.
It will not matter, BP will react as they have to, not want to. We are way past the years it will take to prove this out. It will be a matter of months to instill the fear of missing out.
If I was an analyst in biotech investing, I would look at the likelihood of a partnership/buyout of any drug as a reason to jump in. If BP shows no signs of interest, the drug will need to prove itself with smaller deals. If there was no PR's from Gilead or some other HIV market BP relating to them developing other drugs or some info leak that a partnership was in the works with Leronlimab, I think this is not on the radar at all as a stock investment. As much as we blame the OTC, there are stocks on he OTC that see explosive jumps on good news.
It will not matter, BP will react as they have to, not want to. We are way past the years it will take to prove this out. It will be a matter of months to instill the fear of missing out.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼